Drug intelligence / Profile preview

Dongle Gao

Development stage: Unknown
Lead developer: Jingfukang Pharmaceutical
Modality: Small Molecules
Administration: Topical

Overview

Dongle Gao is a Traditional Chinese Medicine (TCM) topical herbal formulation developed and manufactured by Chengde Jingfukang Pharmaceutical. It is primarily used for the relief of pain associated with rheumatism, joint conditions, and musculoskeletal injuries. The product is formulated as a plaster or ointment that is applied topically to the affected area. Its therapeutic effects are derived from a blend of herbal ingredients, including Centella asiatica and Forsythia suspensa, which are traditionally used to activate blood circulation, reduce swelling, and alleviate pain. It is an approved medication in China, categorized under rheumatism and bone disease treatments.

Brand names: Dongle Gao东乐膏
Other names: Dongle Plaster

Beyond the preview

Go deeper on Dongle Gao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dongle Gao.

Explore the full profile